A Review of Liposomes as a Drug Delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives

Liposomes have been considered promising and versatile drug vesicles. Additionally, the current regulatory guidance and future perspectives related to liposomal products are summarized.

⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.

• 1 Compared with traditional drug delivery systems, liposomes exhibit better properties, including site-targeting, sustained or controlled release, protection of drugs from degradation and clearance, superior therapeutic effects, and lower toxic side effects.
• 2 Given these merits, several liposomal drug products have been successfully approved and used in clinics over the last couple of decades.
• 3 In this review, the liposomal drug products approved by the U.S.

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source: